Friday 6 November 2026
Export HNGE’s income statement to Excel — free account
Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
115.84
0.14
−0.12%
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) Net income
Hinge Health Inc.'s net income for fiscal 2025 was −$528.3M, compared with −$11.9M in fiscal 2024. Over the twelve months to 30 June 2026 it was $109.1M. Hinge Health Inc. ranks 6th of 44 Health Information Services companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$528.3M | — |
| FY2024 | −$11.9M | — |
| FY2023 | −$108.1M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $43.7M | 24.37% |
| Mar 2026 | $35.1M | 9.45% |
| Dec 2025 | $32.1M | — |
| Sep 2025 | −$1.8M | — |
| 5 more quarters | Free account |
Net income against peers
| Company | Net income |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $410.4M |
| HQY HealthEquity, Inc. compare | $236.5M |
| DOCS Doximity, Inc. compare | $139.7M |
| WAY Waystar Holding Corp. compare | $135.2M |
| HNGE Hinge Health Inc. | $109.1M |
| PRVA Privia Health Group, Inc. compare | $38.6M |
| SDGR Schrodinger, Inc. compare | −$59.3M |
| HTFL Heartflow, Inc. compare | −$118.4M |
| TEM Tempus AI, Inc. compare | −$189.3M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on HNGE
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement